Clinical Trials Directory

Trials / Completed

CompletedNCT04308811

Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome

Platelet-Rich Plasma in the Management of Asherman Syndrome

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to find out the benefit of the platelet-rich plasma in preventing reformation of intrauterine adhesions after adhesiolysis in cases of Asherman syndrome

Detailed description

Patients fulfilling criteria will be randomized into three equal groups. The patients who are diagnosed previously with severe AS will choose an envelope which determines the treatment method. There will be 60 envelops assigning for the groups mixed together in one box. This will ensure a randomized allocation of patients to either group of this study. Hysteroscopy adhesiolysis will be done to all participants in the study. in the first group, Adhesiolysis will be followed by intrauterine use of PRP then insertion of intrauterine Foley balloon catheter that will be inflated and left for 2 weeks. in the second group, adhesiolysis will be followed by insertion of intrauterine Foley balloon catheter covered by freeze-dried amniotic graft and will be inflated and left for 2 weeks. In the third group, Adhesiolysis will be followed by insertion of intrauterine Foley balloon catheter that will be inflated and left for 2 weeks. All patients will be given antibiotics and hormonal treatment. Also, they will be given low dose aspirin and sildenafil 50mg daily.

Conditions

Interventions

TypeNameDescription
BIOLOGICALplatelet rich plasmaPlatelet rich plasma and intrauterine balloon applied intrauterine after hysteroscopic adhesiolysis of intrauterine adhesions
COMBINATION_PRODUCTamniotic membrane graft groupamniotic membrane applied on the intrauterine balloon after hysteroscopic lysis of intrauterine adhesions
DEVICEIntrauterine balloonintrauterine balloon applied intrauterine after hysteroscopic lysis of intrauterine adhesions

Timeline

Start date
2019-08-10
Primary completion
2020-02-20
Completion
2020-02-20
First posted
2020-03-16
Last updated
2020-03-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04308811. Inclusion in this directory is not an endorsement.